Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group

Vaccine

Volumn 35, Issue 43, 2017, Pages 5738-5750

  Fell, Deshayne B ^a   Azziz Baumgartner, Eduardo ^b   Baker, Michael G ^c   Batra, Maneesh ^d   Beauté, Julien ^e   Beutels, Philippe ^f   Bhat, Niranjan ^g,ab   Bhutta, Zulfiqar A ^h,i   Cohen, Cheryl ^j,k,ac   De Mucio, Bremen ^l   Gessner, Bradford D ^m   Gravett, Michael G ^d,n   Katz, Mark A ^o,p,ad   Knight, Marian ^q   Lee, Vernon J ^r   Loeb, Mark ^s   Luteijn, Johannes M ^t   Marshall, Helen ^u   Nair, Harish ^v   Pottie, Kevin ^w,ae   Salam, Rehana A ^i,x   Savitz, David A ^y   Serruya, Suzanne J ^l   Skidmore, Becky ^z   Ortiz, Justin R ^aa   more..

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^f UNIVERSITY OF ANTWERP   (Belgium)

^g PATH   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ AGA KHAN UNIVERSITY   (Pakistan)

^j NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^k UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^l PAN AMERICAN HEALTH ORGANIZATION   (Uruguay)

^m Agence de Medecine Preventive   (France)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^p UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^q UNIVERSITY OF OXFORD   (United Kingdom)

^r NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^s MCMASTER UNIVERSITY   (Canada)

^t QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^u UNIVERSITY OF ADELAIDE   (Australia)

^v UNIVERSITY OF EDINBURGH   (United Kingdom)

^w UNIVERSITY OF OTTAWA   (Canada)

^x UNIVERSITY OF ADELAIDE   (Australia)

^y BROWN UNIVERSITY   (United States)

^z Independent information specialist   (Canada)

^aa WORLD HEALTH ORGANIZATION   (Switzerland)

^ab PATH   (United States)

^ac NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^ad UNIVERSITY OF MICHIGAN   (United States)

^ae UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Immunization; Infants; Influenza; Pregnancy

Indexed keywords

INFLUENZA VACCINE;

ADVERSE EVENT; DISEASE BURDEN; DRUG EFFICACY; HEALTH PROGRAM; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NOTE; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC); WORLD HEALTH ORGANIZATION; FEMALE; IMMUNOLOGY; INFANT; PREGNANCY COMPLICATION; PREVENTIVE HEALTH SERVICE; PROCEDURES; VACCINATION; VIROLOGY;

FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 85028554574     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.08.037     Document Type: Note

References (88)

1. Centers for Disease Control, Influenza. Atkinson, W., Wolfe, S., Hamborsky, J., (eds.) Epidemiol. Prev. Vaccine-Preventable Dis., 12th ed., 2012, Public Health Foundation, Washington, D.C.
2. Rothberg, M.B., Haessler, S.D., Brown, R.B., Complications of viral influenza. Am J Med 121 (2008), 258–264.
3. Steinhoff, M.C., Epidemiology and Prevention of Influenza. Nelson, K., Masters Williams, C., (eds.) Infect. Dis. Epidemiol. Theory Pract., 2007, Jones and Bartlett Publishers, Sudbury, MA, 577–600.
4. Siston, A.M., Rasmussen, S.A., Honein, M.A., Fry, A.M., Seib, K., Callaghan, W.M., et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 303 (2010), 1517–1525.
5. Poehling, K.A., Edwards, K.M., Griffin, M.R., Szilagyi, P.G., Staat, M.A., Iwane, M.K., et al. The burden of influenza in young children, 2004–2009. Pediatrics 131 (2013), 207–216.
6. Poehling, K.A., Edwards, K.M., Weinberg, G.A., Szilagyi, P., Staat, M.A., Iwane, M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 355 (2006), 31–40.
7. Neuzil, K.M., Mellen, B.G., Wright, P.F., Mitchel, E.F., Griffin, M.R., The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000), 225–231.
8. Montes, M., Vicente, D., Perez-Yarza, E.G., Cilla, G., Perez-Trallero, E., Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: A 3-year study (July 2001–June 2004). Vaccine. 23 (2005), 4302–4306.
9. Izurieta, H.S., Thompson, W.W., Kramarz, P., Shay, D.K., Davis, R.L., DeStefano, F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 (2000), 232–239.
10. Bhat, N., Wright, J.G., Broder, K.R., Murray, E.L., Greenberg, M.E., Glover, M.J., et al. Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med 353 (2005), 2559–2567.
11. Fiore, A.E., Uyeki, T.M., Broder, K., Finelli, L., Euler, G.L., Singleton, J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59 (2010), 1–62.
12. World Health Organization, Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec 47 (2012), 461–476.
13. Ortiz, J.R., Neuzil, K.M., Ahonkhai, V.I., Gellin, B.G., Salisbury, D.M., Read, J.S., et al. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine 30 (2012), 7134–7140.
14. Kay, A.W., Blish, C.A., Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Front Immunol, 6, 2015, 289.
15. Zaman, K., Roy, E., Arifeen, S.E., Rahman, M., Raqib, R., Wilson, E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 (2008), 1555–1564.
16. Madhi, S.A., Cutland, C.L., Kuwanda, L., Weinberg, A., Hugo, A., Jones, S., et al. Influenza Vaccination of Pregnant Women and Protection of Their Infants. N Engl J Med 371 (2014), 918–931.
17. Steinhoff, M.C., MacDonald, N., Pfeifer, D., Muglia, L.J., Influenza vaccine in pregnancy: policy and research strategies. Lancet 383 (2014), 1611–1613.
18. Fell, D.B., Platt, R.W., Lanes, A., Wilson, K., Kaufman, J.S., Basso, O., et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 122 (2015), 17–26.
19. Savitz, D.A., Fell, D.B., Ortiz, J.R., Bhat, N., Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine 33 (2015), 6430–6435.
20. Vazquez-Benitez, G., Kharbanda, E.O., Naleway, A.L., Lipkind, H., Sukumaran, L., McCarthy, N.L., et al. Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies. Am J Epidemiol 184 (2016), 176–186.
21. Hutcheon, J.A., Savitz, D.A., Invited commentary: influenza, influenza immunization, and pregnancy-it's about time. Am J Epidemiol 184 (2016), 187–191.
22. Fell, D.B., Bhutta, Z.A., Hutcheon, J.A., Karron, R.A., Knight, M., Kramer, M.S., et al. Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015. Vaccine 35 (2017), 2279–2287.
23. Ortiz, J.R., Perut, M., Dumolard, L., Wijesinghe, P.R., Jorgensen, P., Ropero, A.M., et al. A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF joint reporting form on immunization. Vaccine 34 (2016), 5400–5405.
24. Global Alliance for Vaccines and Immunisation (GAVI). Final vaccine investment strategy analysis 2013: maternal influenza [Internet]; 2013. p. 12. Available from: < http://www.gavi.org/about/strategy/vaccine-investment-strategy/>.
25. World Health Organization, WHO taskforce to evaluate influenza data to inform vaccine impact and economic modelling [Internet]. 2014, Switzerland, Geneva.
26. Guyatt, G., Oxman, A.D., Akl, E.a., Kunz, R., Vist, G., Brozek, J., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64 (2011), 383–394.
27. Tapia, M.D., Sow, S.O., Tamboura, B., Tégueté, I., Pasetti, M.F., Kodio, M., et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis 16 (2016), 1026–1035.
28. Steinhoff, M.C., Katz, J., Englund, J.A., Khatry, S.K., Shrestha, L., Kuypers, J., et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis, 2017 pii: S1473-3099(17)30252-9.
29. Katz, M.A., Gessner, B.D., Johnson, J., Skidmore, B., Knight, M., Bhat, N., et al. Incidence of influenza virus infection among pregnant women: a systematic review. BMC Preg Childbirth, 17, 2017, 155.
30. Fell, D.B., Johnson, J., Mor, Z., Katz, M.A., Skidmore, B., Neuzil, K.M., et al. Incidence of laboratory-confirmed influenza disease among infants under six months of age: a systematic review. BMJ Open, 2017, e016526, 10.1136/bmjopen-2017-016526 [in press].
31. Mertz, D., Geraci, J., Winkup, J., Gessner, B.D., Ortiz, J.R., Loeb, M., Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine 35 (2017), 521–528.
32. Fell, D.B., Savitz, D.A., Kramer, M.S., Gessner, B.D., Katz, M.A., Knight, M., et al. Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG 124 (2017), 48–59.
33. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos MTP. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute.
34. Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
35. Huguet, A., Hayden, J.A., Stinson, J., McGrath, P.J., Chambers, C.T., Tougas, M.E., et al. Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework. Syst Rev, 2, 2013, 71.
36. Schanzer, D.L., Langley, J.M., Tam, T.W.S., Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J. Obstet Gynaecol Can 29 (2007), 622–629.
37. Dodds, L., McNeil, S.A., Fell, D.B., Allen, V.M., Coombs, A., Scott, J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176 (2007), 463–468.
38. Neuzil, K.M., Reed, G.W., Mitchel, E.F., Simonsen, L., Griffin, M.R., Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 148 (1998), 1094–1102.
39. Jackson, M.L., Confounding by season in ecologic studies of seasonal exposures and outcomes: examples from estimates of mortality due to influenza. Ann Epidemiol 19 (2009), 681–691.
40. Thompson, W.W., Shay, D.K., Weintraub, E., Brammer, L., Cox, N., Anderson, L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289 (2003), 179–186.
41. Zhou, H., Thompson, W.W., Viboud, C.G., Ringholz, C.M., Cheng, P.-Y., Steiner, C., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis 54 (2012), 1427–1436.
42. Tempia, S., Walaza, S., Cohen, A.L., von Mollendorf, C., Moyes, J., McAnerney, J.M., et al. Mortality associated with seasonal and pandemic influenza among pregnant and nonpregnant women of childbearing age in a high-HIV-prevalence setting-South Africa, 1999–2009. Clin. Infect. Dis. 61 (2015), 1063–1070.
43. McMorrow, M.L., Emukule, G.O., Njuguna, H.N., Bigogo, G., Montgomery, J.M., Nyawanda, B., et al. The Unrecognized burden of influenza in young Kenyan Children, 2008–2012. PLoS One 10 (2015), 2008–2012.
44. Yu, H., Huang, J., Huai, Y., Guan, X., Klena, J., Liu, S., et al. The substantial hospitalization burden of influenza in central China: surveillance for severe, acute respiratory infection, and influenza viruses, 2010–2012. Influenza Other Respi Viruses 8 (2014), 53–65.
45. Libster, R., Bugna, J., Coviello, S., Hijano, D.R., Dunaiewsky, M., Reynoso, N., et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 362 (2010), 45–55.
46. Nair, H., Brooks, W.A., Katz, M., Roca, A., Berkley, J.A., Madhi, S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378 (2011), 1917–1930.
47. Doyle, T.J., Goodin, K., Hamilton, J.J., Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) illness in Florida, 2009–2010: a population-based cohort study. PLoS One, 8, 2013, e79040.
48. Pierce, M., Kurinczuk, J.J., Spark, P., Brocklehurst, P., Knight, M., Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ, 342, 2011, d3214.
49. Håberg, S.E., Trogstad, L., Gunnes, N., Wilcox, A.J., Gjessing, H.K., Samuelsen, S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 368 (2013), 333–340.
50. Hansen, C., Desai, S., Bredfeldt, C., Cheetham, C., Gallagher, M., Li, D.-K., et al. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis 206 (2012), 1260–1268.
51. Naresh, A., Fisher, B.M., Hoppe, K.K., Catov, J., Xu, J., Hart, J., et al. A multicenter cohort study of pregnancy outcomes among women with laboratory-confirmed H1N1 influenza. J Perinatol 33 (2013), 939–943.
52. McNeil, S.A., Dodds, L.A., Fell, D.B., Allen, V.M., Halperin, B.A., Steinhoff, M.C., et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 204 (2011), S54–S57.
53. Feikin, D.R., Scott, J.A.G., Gessner, B.D., Use of vaccines as probes to define disease burden. Lancet 383 (2014), 1762–1770.
54. Widelock, D., Csizmas, L., Klein, S., Influenza, pregnancy, and fetal outcome. Public Health Rep 78 (1963), 1–11.
55. Gérardin, P., El Amrani, R., Cyrille, B., Gabrièle, M., Guillermin, P., Boukerrou, M., et al. Low clinical burden of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La Réunion. PLoS One, 5, 2010, e10896.
56. Malinowski, A.K., McGeer, A., Robertson, J., Sermer, M., Farine, D., Lapinsky, S.E., et al. H1N1 in pregnancy: a tertiary care centre experience. J Obstet Gynaecol Can 33 (2011), 698–704.
57. Mosby, L.G., Rasmussen, S.A., Jamieson, D.J., 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 205 (2011), 10–18.
58. Harris, J., Influenza occurring in pregnant women. J Am Med Assoc 72 (1919), 978–980.
59. Freeman, D.W., Barno, A., Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 78 (1959), 1172–1175.
60. Liu, S.-L., Wang, J., Yang, X.-H., Chen, J., Huang, R.-J., Ruan, B., et al. Pandemic influenza A(H1N1) 2009 virus in pregnancy. Rev Med Virol 23 (2013), 3–14.
61. Bhalerao-Gandhi, A., Chhabra, P., Arya, S., Simmerman, J.M., Influenza and pregnancy: a review of the literature from India. Infect Dis Obstet Gynecol, 2015, 2015, 867587.
62. Meijer, W.J., van Noortwijk, A.G.A., Bruinse, H.W., Wensing, A.M.J., Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand 94 (2015), 797–819.
63. Moro, P.L., Broder, K., Zheteyeva, Y., Revzina, N., Tepper, N., Kissin, D., et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol, 205, 2011 473.e1-9.
64. Salam, R.A., Das, J.K., Dojo Soeandy, C., Lassi, Z.S., Bhutta, Z.A., Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. Cochrane Database Syst Rev, 2015, CD009982.
65. McMillan, M., Porritt, K., Kralik, D., Costi, L., Marshall, H., Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine 33 (2015), 2108–2117.
66. Hutcheon, J.A., Fell, D.B., Jackson, M.L., Kramer, M.S., Ortiz, J.R., Savitz, D.A., et al. Detectable risks in studies of the fetal benefits of maternal influenza vaccination. Am J Epidemiol 184 (2016), 227–232.
67. Nelson, J.C., Jackson, M.L., Weiss, N.S., Jackson, L.A., New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 62 (2009), 687–694.
68. Simonsen, L., Viboud, C., Taylor, R.J., Miller, M.A., Jackson, L., Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine 27 (2009), 6300–6304.
69. Steinhoff, M.C., Omer, S.B., Roy, E., El Arifeen, S., Raqib, R., Dodd, C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 184 (2012), 645–653.
70. Simões, E.A.F., Cutland, C., Carosone-Link, P., Hugo, A., Jones, S., Madimabe, R., et al. Lack of efficacy of trivalent influenza vaccination of HIV-negative pregnant women against adverse fetal outcomes: a randomized clinical trial. Open Forum Infect Dis, 2, 2015, 10.1093/ofid/ofv133.1446.
71. Omer, S.B., Richards, J.L., Madhi, S.A., Tapia, M.D., Steinhoff, M.C., Aqil, A.R., et al. Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: Methods and expectations. Vaccine 33 (2015), 3801–3812.
72. World Health Organization. WHO Preferred Product Characteristics for Next-Generation Influenza Vaccines. Geneva; 2017.
73. Ortiz, J.R., Englund, J.A., Neuzil, K.M., Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 29 (2011), 4439–4452.
74. Lambach, P., Hombach, J., Ortiz, J.R., A global perspective of maternal influenza immunization. Vaccine 33 (2015), 6376–6379.
75. Sobanjo-ter Meulen, A., Abramson, J., Mason, E., Rees, H., Schwalbe, N., Bergquist, S., et al. Path to impact: a report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin – January 29–30, 2015. Vaccine 33 (2015), 6388–6395.
76. Fell, D.B., Sprague, A.E., Liu, N., Yasseen, A.S., Wen, S.-W., Smith, G., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 102 (2012), e33–e40.
77. Bonhoeffer, J., Kochhar, S., Hirschfeld, S., Heath, P.T., Jones, C.E., Bauwens, J., et al. Global alignment of immunization safety assessment in pregnancy – the GAIA project. Vaccine 34 (2016), 5993–5997.
78. Fitchett, E.J.A., Seale, A.C., Vergnano, S., Sharland, M., Heath, P.T., Saha, S.K., et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis 16 (2016), e202–e213.
79. World Health Organization, A manual for estimating disease burden associated with seasonal influenza. 2015, World Health Organization, Geneva.
80. Nunes, M.C., Cutland, C.L., Jones, S., Downs, S., Weinberg, A., Ortiz, J.R., et al. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial. Clin Infect Dis, 2017, 10.1093/cid/cix497.
81. Gessner, B.D., Brooks, W.A., Neuzil, K.M., Vernet, G., Bright, R.A., Tam, J.S., et al. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine 31 (2013), 3222–3228.
82. Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations. Wkly Epidemiol Rec 90 (2015), 261–278.
83. Anand, A., Luman, E.T., O'Connor, P.M., Building on success–potential to improve coverage of multiple health interventions through integrated delivery with routine childhood vaccination. J Infect Dis 205:Suppl (2012), S28–S39.
84. Health P for MN and C. PMNCH Knowledge Summary # 25: Integrating Immunization and Other Services for Women and Children [Internet]. 2013. Available from: < http://www.who.int/pmnch/knowledge/publications/summaries/ks25/en/> [cited 2017 Jul 14].
85. World Health Organization, Global pandemic influenza action plan to increase vaccine supply. 2006, Switzerland, Geneva.
86. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
87. Riquelme, R., Jiménez, P., Videla, A.J., Lopez, H., Chalmers, J., Singanayagam, A., et al. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis 15 (2011), 542–546.
88. Van Kerkhove, M.D., Vandemaele, K.A.H., Shinde, V., Jaramillo-Gutierrez, G., Koukounari, A., Donnelly, C.A., et al. Risk factors for severe outcomes following 2009 Influenza A (H1N1) Infection: a global pooled analysis. PLoS Med, 8, 2011, e1001053.